Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1750790
PUBLISHER: Grand View Research | PRODUCT CODE: 1750790
U.S. Biobanks Market Size, Share & Trends Analysis Report By Product & Service, By Biospecimen (Human Tissues, Organs, Stem Cells), By Type (Physical/Real Biobanks, Virtual Biobanks), By Application, By Region, And Segment Forecasts, 2025 - 2030
PUBLISHED:
PAGES: 90 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
U.S. Biobanks Market Growth & Trends:
The U.S. biobanks market size is anticipated to reach USD 24.48 billion by 2030 and is projected to grow at a CAGR of 6.26% from 2025 to 2030, according to a new report by Grand View Research, Inc. This growth is attributed to rising demand for quality biospecimens in drug development, personalized medicine, and clinical research. Advancements in biobanking technologies, growing investments from pharmaceutical and biotech firms, and expanding applications in genomics and regenerative medicine further drive market expansion.
The increasing emphasis on precision medicine significantly boosts the demand for quality, well-annotated biospecimens across the U.S. healthcare and research landscape. These samples are essential for supporting critical activities such as biomarker discovery, patient stratification, and the development of targeted therapies. Biobanks play a pivotal role in this process by offering reliable access to diverse and clinically relevant biological materials, vital for translational research and drug development. As pharmaceutical companies, research institutions, and diagnostics firms prioritize personalized treatment approaches, the reliance on biobank infrastructure is expected to grow substantially. This trend is poised to drive sustained market demand over the forecast period.
The COVID-19 pandemic significantly accelerated the demand for biobanks in the U.S., driven by the urgent need for biological specimens to support vaccine development, diagnostic innovation, and public health research. Biobanks played a vital role in collecting, preserving, and distributing COVID-19-related samples, enabling faster response to emerging variants and enhancing understanding of disease progression. Their contribution helped accelerate clinical trials, support regulatory approvals, and advance therapeutic and preventive strategies during the pandemic.
However, the U.S. market faces constraints due to high infrastructure and maintenance costs, along with stringent regulatory requirements related to data privacy, informed consent, and sample traceability. These challenges can limit scalability, particularly for smaller institutions and emerging players.
U.S. Biobanks Market Report Highlights:
- The services held the largest market share in 2024 and are anticipated to grow at the fastest CAGR over the forecast period. This is attributed to increasing demand for end-to-end sample management, processing, and storage solutions, especially from the pharma and research sectors. The product segment is expected to grow significantly over the forecast period.
- The human tissues segment dominated with a market share of 36.91% in 2024. This is driven by their critical role in disease research, biomarker discovery, and drug development, particularly in oncology and regenerative medicine. However, stem cells are anticipated to grow at the fastest CAGR of 7.40% over the forecast period.
- The physical/real biobank held the largest market share in 2024. This is driven by their established infrastructure, ability to store diverse biospecimens under controlled conditions, and widespread use in clinical trials and translational research. However, virtual biobank types are anticipated to grow at the fastest CAGR over the forecast period.
- The therapeutics segment dominated the application segment with the largest share in 2024 and is anticipated to grow at the fastest CAGR over the forecast period. This is driven by the increasing use of biobanked samples in developing targeted treatments, regenerative therapies, and personalized medicine approaches. However, clinical diagnostics are expected to grow significantly over the forecast period.
Product Code: GVR-4-68040-585-1
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.2.1. Products & Services Segment
- 1.2.2. Biospecimen Segment
- 1.2.3. Type Segment
- 1.2.4. Application Segment
- 1.3. Information analysis
- 1.4. Market formulation & data visualization
- 1.5. Data validation & publishing
- 1.6. Information Procurement
- 1.6.1. Primary Research
- 1.7. Information or Data Analysis
- 1.8. Market Formulation & Validation
- 1.9. Market Model
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Increased focus on precision medicine and genetic testing
- 3.2.1.2. Changes in biobanking operations
- 3.2.1.3. Increase in the number of clinical trials
- 3.2.1.4. Growing biobanking industry and research collaborations
- 3.2.1.5. Technology advancement and automation
- 3.2.2. Market restraint analysis
- 3.2.2.1. Challenges in sharing biobanking data & limited access to biospecimens
- 3.2.2.2. Sustainability challenges for biobanks
- 3.2.2.3. Challenges associated with biobanking specimen management
- 3.2.1. Market driver analysis
- 3.3. U.S. Biobanks Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis
Chapter 4. U.S. Biobanks Market: Ingredient Estimates & Trend Analysis
- 4.1. Products & Services Segment Dashboard
- 4.2. U.S. Biobanks Market Products & Services Movement Analysis
- 4.3. U.S. Biobanks Market Size & Trend Analysis, by Products & Services, 2018 to 2030 (USD Million)
- 4.4. Products
- 4.4.1. Products Market, 2018 - 2030 (USD Million)
- 4.4.2. Biobanking Equipment
- 4.4.2.1. Biobanking Equipment Market, 2018 - 2030 (USD Million)
- 4.4.2.2. Temperature Control Systems
- 4.4.2.2.1. Temperature Control Systems Market, 2018 - 2030 (USD Million)
- 4.4.2.2.2. Freezers & Refrigerators
- 4.4.2.2.2.1. Freezers & Refrigerators Market, 2018 - 2030 (USD Million)
- 4.4.2.2.3. Cryogenic Storage Systems
- 4.4.2.2.3.1. Cryogenic Storage Systems Market, 2018 - 2030 (USD Million)
- 4.4.2.2.4. Thawing Equipment
- 4.4.2.2.4.1. Thawing Equipment Market, 2018 - 2030 (USD Million)
- 4.4.2.3. Incubators & Centrifuges
- 4.4.2.3.1. Incubators & Centrifuges Market, 2018 - 2030 (USD Million)
- 4.4.2.4. Alarms & Monitoring Systems
- 4.4.2.4.1. Alarms & Monitoring Systems Market, 2018 - 2030 (USD Million)
- 4.4.2.5. Accessories & Other Equipment
- 4.4.2.5.1. Accessories & Other Equipment Market, 2018 - 2030 (USD Million)
- 4.4.3. Biobanking Consumables
- 4.4.3.1. Biobanking Consumables Market, 2018 - 2030 (USD Million)
- 4.4.4. Laboratory Information Management Systems
- 4.4.4.1. Laboratory Information Management Systems Market, 2018 - 2030 (USD Million)
- 4.5. Services
- 4.5.1. Services Market, 2018 - 2030 (USD Million)
- 4.5.2. Biobanking & Repository
- 4.5.2.1. Biobanking & Repository Market, 2018 - 2030 (USD Million)
- 4.5.3. Lab processing
- 4.5.3.1. Lab processing Market, 2018 - 2030 (USD Million)
- 4.5.4. Qualification/ Validation
- 4.5.4.1. Qualification/ Validation Market, 2018 - 2030 (USD Million)
- 4.5.5. Cold Chain Logistics
- 4.5.5.1. Cold Chain Logistics Market, 2018 - 2030 (USD Million)
- 4.5.6. Other Services
- 4.5.6.1. Other Services Market, 2018 - 2030 (USD Million)
Chapter 5. U.S. Biobanks Market: Biospecimen Estimates & Trend Analysis
- 5.1. Biospecimen Segment Dashboard
- 5.2. U.S. Biobanks Market Biospecimen Movement Analysis
- 5.3. U.S. Biobanks Market Size & Trend Analysis, by Biospecimen, 2018 to 2030 (USD Million)
- 5.4. Human Tissues
- 5.4.1. Human Tissues Market, 2018 - 2030 (USD Million)
- 5.5. Organs
- 5.5.1. Organs Market, 2018 - 2030 (USD Million)
- 5.6. Stem Cells
- 5.6.1. Stem Cells Market, 2018 - 2030 (USD Million)
- 5.6.2. Adult Stem Cells
- 5.6.2.1. Adult Stem Cells Market, 2018 - 2030 (USD Million)
- 5.6.3. Embryonic Stem Cells
- 5.6.3.1. Embryonic Stem Cells Market, 2018 - 2030 (USD Million)
- 5.6.4. IPS Cells
- 5.6.4.1. IPS Cells Market, 2018 - 2030 (USD Million)
- 5.6.5. Other Stem Cells
- 5.6.5.1. Other Stem Cells Market, 2018 - 2030 (USD Million)
- 5.7. Other Biospecimens
- 5.7.1. Other Biospecimens Market, 2018 - 2030 (USD Million)
Chapter 6. U.S. Biobanks Market: Type Estimates & Trend Analysis
- 6.1. Type Segment Dashboard
- 6.2. U.S. Biobanks Market Type Movement Analysis
- 6.3. U.S. Biobanks Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
- 6.4. Physical/Real Biobanks
- 6.4.1. Physical/Real Biobanks Market, 2018 - 2030 (USD Million)
- 6.4.2. Tissue Biobanks
- 6.4.2.1. Tissue Biobanks Market, 2018 - 2030 (USD Million)
- 6.4.3. Population Based Biobanks
- 6.4.3.1. Population Based Biobanks Market, 2018 - 2030 (USD Million)
- 6.4.4. Genetic (DNA/RNA)
- 6.4.4.1. Genetic (DNA/RNA) Market, 2018 - 2030 (USD Million)
- 6.4.5. Disease Based Biobanks
- 6.4.5.1. Disease Based Biobanks Market, 2018 - 2030 (USD Million)
- 6.5. Virtual Biobanks
- 6.5.1. Virtual Biobanks Market, 2018 - 2030 (USD Million)
Chapter 7. U.S. Biobanks Market: Application Estimates & Trend Analysis
- 7.1. Application Segment Dashboard
- 7.2. U.S. Biobanks Market Application Movement Analysis
- 7.3. U.S. Biobanks Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
- 7.4. Therapeutics
- 7.4.1. Therapeutics Market, 2018 - 2030 (USD Million)
- 7.5. Drug Discovery & Clinical Research
- 7.5.1. Drug Discovery & Clinical Research Market, 2018 - 2030 (USD Million)
- 7.6. Clinical Diagnostics
- 7.6.1. Clinical Diagnostics Market, 2018 - 2030 (USD Million)
- 7.7. Other Application
- 7.7.1. Other Application Market, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Company Categorization
- 8.2. Strategy Mapping
- 8.3. Company Profiles/Listing
- 8.3.1. Thermo Fisher Scientific, Inc.
- 8.3.1.1. Overview
- 8.3.1.2. Financial Performance
- 8.3.1.3. Product Benchmarking
- 8.3.1.4. Strategic Initiatives
- 8.3.2. Merck KGaA
- 8.3.2.1. Overview
- 8.3.2.2. Financial Performance
- 8.3.2.3. Product Benchmarking
- 8.3.2.4. Strategic Initiatives
- 8.3.3. QIAGEN
- 8.3.3.1. Overview
- 8.3.3.2. Financial Performance
- 8.3.3.3. Product Benchmarking
- 8.3.3.4. Strategic Initiatives
- 8.3.4. Hamilton Company
- 8.3.4.1. Overview
- 8.3.4.2. Financial Performance
- 8.3.4.3. Product Benchmarking
- 8.3.4.4. Strategic Initiatives
- 8.3.5. Tecan Trading Ag
- 8.3.5.1. Overview
- 8.3.5.2. Financial Performance
- 8.3.5.3. Product Benchmarking
- 8.3.5.4. Strategic Initiatives
- 8.3.6. ViaCord (Revitty)
- 8.3.6.1. Overview
- 8.3.6.2. Financial Performance
- 8.3.6.3. Product Benchmarking
- 8.3.6.4. Strategic Initiatives
- 8.3.7. Cryo-Cell
- 8.3.7.1. Overview
- 8.3.7.2. Financial Performance
- 8.3.7.3. Product Benchmarking
- 8.3.7.4. Strategic Initiatives
- 8.3.8. BioCision, Llc.
- 8.3.8.1. Overview
- 8.3.8.2. Financial Performance
- 8.3.8.3. Product Benchmarking
- 8.3.8.4. Strategic Initiatives
- 8.3.9. Icbiomedical
- 8.3.9.1. Overview
- 8.3.9.2. Financial Performance
- 8.3.9.3. Product Benchmarking
- 8.3.9.4. Strategic Initiatives
- 8.3.10. Charles River Laboratories
- 8.3.10.1. Overview
- 8.3.10.2. Financial Performance
- 8.3.10.3. Product Benchmarking
- 8.3.10.4. Strategic Initiatives
- 8.3.11. Azenta US Inc.
- 8.3.11.1. Overview
- 8.3.11.2. Financial Performance
- 8.3.11.3. Product Benchmarking
- 8.3.11.4. Strategic Initiatives
- 8.3.12. Stemcell Technologies
- 8.3.12.1. Overview
- 8.3.12.2. Financial Performance
- 8.3.12.3. Product Benchmarking
- 8.3.12.4. Strategic Initiatives
- 8.3.13. Biovault Family
- 8.3.13.1. Overview
- 8.3.13.2. Financial Performance
- 8.3.13.3. Product Benchmarking
- 8.3.13.4. Strategic Initiatives
- 8.3.14. LabVantage Solutions Inc.
- 8.3.14.1. Overview
- 8.3.14.2. Financial Performance
- 8.3.14.3. Product Benchmarking
- 8.3.14.4. Strategic Initiatives
- 8.3.15. Precision Cellular Storage Ltd.
- 8.3.15.1. Overview
- 8.3.15.2. Financial Performance
- 8.3.15.3. Product Benchmarking
- 8.3.15.4. Strategic Initiatives
- 8.3.1. Thermo Fisher Scientific, Inc.
Product Code: GVR-4-68040-585-1
List of Tables
- Table 1. U.S. biobanks market estimates & forecasts
- Table 2. U.S. biobanks market estimates & forecasts, by products & services, 2018 - 2030 (USD Million)
- Table 3. U.S. biobanks market estimates & forecasts, by biospecimen, 2018 - 2030 (USD Million)
- Table 4. U.S. biobanks market estimates & forecasts, by type, 2018 - 2030 (USD Million)
- Table 5. U.S. biobanks market estimates & forecasts, by application, 2018 - 2030 (USD Million)
List of Figures
- Fig. 1 Market snapshot
- Fig. 2 Market research process
- Fig. 3 Information procurement
- Fig. 4 Primary research pattern
- Fig. 5 Market research approaches
- Fig. 6 Market trends & outlook
- Fig. 7 Market segmentation & scope
- Fig. 8 Market driver relevance analysis (Current & future impact)
- Fig. 9 Market restraint relevance analysis (Current & future impact)
- Fig. 10 PESTLE Analysis
- Fig. 11 Porter's Five Forces Analysis
- Fig. 12 Strategy framework
- Fig. 13 Participant categorization
- Fig. 14 U.S. biobanks market: Products & services outlook key takeaways
- Fig. 15 U.S. biobanks market: Products & services movement analysis
- Fig. 16 Products market, 2018 - 2030 (USD Million)
- Fig. 17 Biobanking equipment market, 2018 - 2030 (USD Million)
- Fig. 18 Temperature control systems market, 2018 - 2030 (USD Million)
- Fig. 19 Freezers & refrigerators market, 2018 - 2030 (USD Million)
- Fig. 20 Cryogenic storage systems market, 2018 - 2030 (USD Million)
- Fig. 21 Thawing equipment market, 2018 - 2030 (USD Million)
- Fig. 22 Incubators & centrifuges market, 2018 - 2030 (USD Million)
- Fig. 23 Alarms & monitoring systems market, 2018 - 2030 (USD Million)
- Fig. 24 Accessories & other equipment market, 2018 - 2030 (USD Million)
- Fig. 25 Biobanking consumables market, 2018 - 2030 (USD Million)
- Fig. 26 Laboratory information management systems market, 2018 - 2030 (USD Million)
- Fig. 27 Services market, 2018 - 2030 (USD Million)
- Fig. 28 Biobanking & repository market, 2018 - 2030 (USD Million)
- Fig. 29 Lab processing market, 2018 - 2030 (USD Million)
- Fig. 30 Qualification/validation market, 2018 - 2030 (USD Million)
- Fig. 31 Cold chain logistics market, 2018 - 2030 (USD Million)
- Fig. 32 Other services market, 2018 - 2030 (USD Million)
- Fig. 33 U.S. biobanks market: Biospecimen outlook key takeaways
- Fig. 34 U.S. biobanks market: Biospecimen movement analysis
- Fig. 35 Human tissues market, 2018 - 2030 (USD Million)
- Fig. 36 Organs market, 2018 - 2030 (USD Million)
- Fig. 37 Stem cells tissues market, 2018 - 2030 (USD Million)
- Fig. 38 Adult stem cells market, 2018 - 2030 (USD Million)
- Fig. 39 Embryonic stem cells market, 2018 - 2030 (USD Million)
- Fig. 40 IPS cells market, 2018 - 2030 (USD Million)
- Fig. 41 Other stem cells market, 2018 - 2030 (USD Million)
- Fig. 42 Other biospecimens market, 2018 - 2030 (USD Million)
- Fig. 43 U.S. biobanks market: Type outlook key takeaways
- Fig. 44 U.S. biobanks market: Type movement analysis
- Fig. 45 Physical/real biobanks market, 2018 - 2030 (USD Million)
- Fig. 46 Tissue biobanks market, 2018 - 2030 (USD Million)
- Fig. 47 Population-based biobanks market, 2018 - 2030 (USD Million)
- Fig. 48 Genetic (DNA/RNA) market, 2018 - 2030 (USD Million)
- Fig. 49 Disease-based biobanks market, 2018 - 2030 (USD Million)
- Fig. 50 Virtual biobanks market, 2018 - 2030 (USD Million)
- Fig. 51 U.S. biobanks market: Application outlook key takeaways
- Fig. 52 U.S. biobanks market: Application movement analysis
- Fig. 53 Therapeutics market, 2018 - 2030 (USD Million)
- Fig. 54 Drug discovery & clinical research market, 2018 - 2030 (USD Million)
- Fig. 55 Clinical diagnostics market, 2018 - 2030 (USD Million)
- Fig. 56 Other application market, 2018 - 2030 (USD Million)
- Fig. 57 U.S. biobanks market, 2018 - 2030 (USD Million)
- Fig. 58 Key companies profiled
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.